- Home
- BOF vs CRIS Comparison
BOF vs CRIS Comparison
Compare BOF & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- CRIS
- Stock Information
- Founded
- BOF 2017
- CRIS 2000
- Country
- BOF United States
- CRIS United States
- Employees
- BOF N/A
- CRIS N/A
- Industry
- BOF Packaged Foods
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOF Consumer Staples
- CRIS Health Care
- Exchange
- BOF Nasdaq
- CRIS Nasdaq
- Market Cap
- BOF 18.8M
- CRIS 21.3M
- IPO Year
- BOF 2023
- CRIS 2000
- Fundamental
- Price
- BOF $2.34
- CRIS $2.19
- Analyst Decision
- BOF
- CRIS Strong Buy
- Analyst Count
- BOF 0
- CRIS 2
- Target Price
- BOF N/A
- CRIS $16.50
- AVG Volume (30 Days)
- BOF 83.9K
- CRIS 76.0K
- Earning Date
- BOF 08-13-2025
- CRIS 07-31-2025
- Dividend Yield
- BOF N/A
- CRIS N/A
- EPS Growth
- BOF N/A
- CRIS N/A
- EPS
- BOF N/A
- CRIS N/A
- Revenue
- BOF $8,242,843.00
- CRIS $11,202,000.00
- Revenue This Year
- BOF N/A
- CRIS N/A
- Revenue Next Year
- BOF N/A
- CRIS $10.67
- P/E Ratio
- BOF N/A
- CRIS N/A
- Revenue Growth
- BOF 96.47
- CRIS 14.17
- 52 Week Low
- BOF $0.61
- CRIS $1.02
- 52 Week High
- BOF $4.11
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- BOF 60.31
- CRIS 50.37
- Support Level
- BOF $1.91
- CRIS $2.11
- Resistance Level
- BOF $2.47
- CRIS $2.26
- Average True Range (ATR)
- BOF 0.15
- CRIS 0.20
- MACD
- BOF 0.03
- CRIS -0.04
- Stochastic Oscillator
- BOF 62.50
- CRIS 16.85
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.